What Purity Should CJC-1295 (No DAC) Be?

For reliable in vitro and animal models, CJC-1295 (No DAC) purity percentage should meet or exceed 98.0% as measured by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). PX1 Research sets the benchmark for laboratory peptide procurement by pairing USA synthesis with third-party lot-specific COA verification, LC-MS identity testing, endotoxin screening, and same-day dispatch from our California and Arizona logistics facilities.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

For reliable in vitro and animal models, CJC-1295 (No DAC) purity percentage should meet or exceed 98.0% as measured by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). PX1 Research sets the benchmark for laboratory peptide procurement by pairing USA synthesis with third-party lot-specific COA verification, LC-MS identity testing, endotoxin screening, and same-day dispatch from our California and Arizona logistics facilities.

Reviewed by PX1 Research scientific team

Key takeaways

  • In analytical chemistry and cell culture applications, research-grade [CJC-1295](/research-peptides/cjc-1295-no-dac) (No DAC)—also designated as Modified GRF 1-29—must demonstrate an RP-HPLC chromatographic purity of at least 98.0%.
  • [CJC-1295](/research-peptides/cjc-1295-no-dac) (No DAC) is a synthetic 29-amino-acid peptide analog of Growth Hormone-Releasing Hormone (GHRH).
  • In preclinical research, inconsistent chemical purity distorts experimental results.
  • Determining the quality of a peptide sample requires two distinct, complementary analytical methods: Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for chemical purity and Mass Spectrometry (LC-MS or ESI-MS) for molecular identity.

At a glance: Essential purity specifications for CJC-1295 (No DAC)

In analytical chemistry and cell culture applications, research-grade CJC-1295 (No DAC)—also designated as Modified GRF 1-29—must demonstrate an RP-HPLC chromatographic purity of at least 98.0%. Anything below 95.0% introduces truncated peptide sequences, deletion peptides, and chemical artifacts that undermine receptor binding kinetics.

Beyond percentage purity, principal investigators must evaluate net peptide content, residual counterions such as trifluoroacetic acid (TFA), moisture levels, and endotoxin burdens. A standard 2 mg or 5 mg vial label reflects the total gross lyophilized mass; the actual active sequence mass depends entirely on the net peptide content percentage.

When sourcing high-purity peptides for laboratory evaluation, researchers require full transparency. You can inspect raw data, mass spectra, and chromatograms when you order 5 mg vials of CJC-1295 (No DAC) verified by independent third-party laboratories.

What is CJC-1295 (No DAC) and how does its molecular structure affect stability?

CJC-1295 (No DAC) is a synthetic 29-amino-acid peptide analog of Growth Hormone-Releasing Hormone (GHRH). As a GHRH analog, it is studied as a long-acting growth-hormone-releasing hormone that sustains GH and downstream IGF-1 levels for tissue repair research. The sequence contains four specific amino acid substitutions (D-Ala2, Gln8, Ala15, and Leu27) compared to native GHRH (1-29) amide, designed to resist rapid cleavage by dipeptidyl peptidase IV (DPP-IV).

Unlike CJC-1295 with DAC (Drug Affinity Complex), which contains a maleimidopropionic acid linker that covalently binds to circulating serum albumin, CJC-1295 (No DAC) lacks this lysine-linker extension. Consequently, its molecular weight sits precisely at 3288.70 Da (monoisotopic mass ~3286.7 Da).

Because it lacks the DAC moiety, CJC-1295 (No DAC) exhibits a shorter half-life in physiological buffered solutions, making precise sequence integrity and high purity vital for reproducibility. Small impurities or truncated fragments (such as des-D-Ala1 or deletion peptides) can competitively block GHRH receptor binding sites without inducing the conformational shift necessary for intracellular cAMP activation. For broader structural data, review our CJC-1295 (No DAC) research overview.

Why is the cjc-1295 (no dac) purity percentage critical in laboratory settings?

In preclinical research, inconsistent chemical purity distorts experimental results. When evaluating receptor affinity, signal transduction pathways, or cellular protein expression, impure peptide batches introduce unquantified variable variables into cell culture media or assay systems.

Truncated or modified sequence impurities often possess similar hydrophobic profiles to the target peptide, competing directly for receptor binding sites. If an assay utilizes a batch with only 85% purity, up to 15% of the gross material consists of unknown sequences, truncated peptide chains, or chemical adducts. This significantly lowers active molar concentrations and introduces noise into assay baseline measurements.

To maintain valid statistical power across experimental cohorts, investigators should only buy reagents that meet a verified minimum threshold of 98.0% purity. Browse our complete catalog of research peptides to source standardized reagents for your laboratory.

RP-HPLC vs. Mass Spectrometry: How purity and identity are calculated

Determining the quality of a peptide sample requires two distinct, complementary analytical methods: Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for chemical purity and Mass Spectrometry (LC-MS or ESI-MS) for molecular identity.

RP-HPLC separates the target sequence from synthesized impurities, truncated fragments, and protecting group adducts based on hydrophobicity over a C18 stationary phase. The cjc-1295 (no dac) purity percentage is calculated by integrating the area under the main target peak relative to the total peak area recorded across the ultraviolet absorption spectrum (typically at 214 nm or 220 nm, where peptide bonds absorb strongly). A result of 98.5% indicates that 98.5% of the light-absorbing peptide mass eluting from the column corresponds to the primary peak.

Mass spectrometry confirms that the primary chromatographic peak actually contains the correct chemical structure. Electrospray Ionization Mass Spectrometry (ESI-MS) measures the mass-to-charge ratio (m/z) of the ionized peptide. For CJC-1295 (No DAC), the mass spectrum must show major multiply-charged species (such as [M+3H]3+ and [M+4H]4+) that reconstruct precisely to the calculated monoisotopic molecular weight of 3288.7 Da.

Understanding net peptide content vs. gross vial weight

A common point of confusion among lab personnel is the distinction between gross lyophilized mass and net peptide content. A vial labeled as containing 2 mg or 5 mg of lyophilized peptide does not consist of 100% pure peptide powder by dry weight.

During solid-phase peptide synthesis (SPPS) and final lyophilization from aqueous buffers containing trifluoroacetic acid (TFA), peptides form salt complexes with basic amino acid residues (such as Lysine, Arginine, and Histidine). Additionally, lyophilized cakes absorb residual moisture from atmospheric exposure during packaging. Consequently, a typical high-purity cake consists of:

1. Active target peptide (typically 75% to 88% of total weight) 2. Counterion salts, primarily TFA or acetate (10% to 15% of total weight) 3. Residual bound moisture/water (3% to 8% of total weight)

Net peptide content (NPC) measures the exact fraction of the lyophilized powder that is actual peptide protein, determined via elemental Nitrogen Analysis (CHN) or Quantitative Amino Acid Analysis (AAA). If a 5 mg vial has a net peptide content of 80%, the vial contains exactly 4.0 mg of pure target sequence peptide. When formulating precise molar concentrations for in vitro assays, researchers must adjust working stock calculations based on the net peptide content reported on the lot-specific Certificate of Analysis.

The role of TFA salts, residual water, and endotoxin levels

The presence of residual manufacturing reagents can skew biological assays if not controlled within strict laboratory thresholds:

Trifluoroacetic Acid (TFA): Standard cleavage protocols from resin matrices use TFA, leaving residual trifluoroacetate counterions attached to basic amine groups. High concentrations of TFA can exhibit cell culture toxicity or alter local pH in unbuffered aqueous media. Standard research grade peptides should contain <15% TFA content, while specialized cell line assays may require acetate conversion.

Moisture Content: Lyophilized powders are hygroscopic. Excess moisture (>8% residual water) accelerates hydrolysis during room temperature handling and shortens shelf-life after reconstitution. Freeze-dried cakes prepared under stringent vacuum conditions maintain moisture levels well below 5%.

Endotoxin Screening: Bacterial endotoxins (lipopolysaccharides) contaminate reagents prepared in non-sterile environments. For sensitive cell culture systems or immunological assays, endotoxin levels should be verified below 0.5 EU/mg, and ideally <0.1 EU/mg. High endotoxin levels trigger false-positive inflammatory signaling in cell models, corrupting experimental outcome data.

How to read a CJC-1295 (No DAC) Certificate of Analysis line by line

To ensure reagent integrity, researchers must verify six distinct fields on a lot-specific COA before preparing experimental solutions:

1. Product Identifier & Lot Code: Must match the physical label affixed to the vial. Lot-level traceability is mandatory for reproducible research.

2. Calculated vs. Observed Molecular Mass: Look for the LC-MS section. The theoretical molecular weight (3288.70 Da) must match the observed mass within ±1.0 Da.

3. RP-HPLC Purity Profile: Verify that the primary peak integration reports ≥98.0%. Review the accompanying UV chromatogram to ensure baseline stability and absence of major split peaks.

4. Physical Appearance: The lyophilized cake should appear as a white, uniform freeze-dried powder. Clumping, discoloration, or liquid residues indicate moisture contamination or poor lyoprotectant ratios.

5. Solubility Assessment: Confirms complete dissolution in sterile deionized water or standard bacteriostatic reconstitution solutions without particulate suspension.

6. Endotoxin & Bioburden Testing: Look for quantitative Limulus Amebocyte Lysate (LAL) assay results reported in EU/mg.

Vendor evaluation: Criteria for sourcing research peptides

When comparing chemical suppliers for research-grade GHRH analogs, use structured evaluation metrics to audit vendor compliance:

Purity Verification: Standard vendors rely on batch synthesis estimates. Premium suppliers issue individual COAs for every production lot using independent third-party RP-HPLC and mass spectrometry testing.

Sourcing and Synthesis: Verify whether the vendor utilizes solid-phase peptide synthesis (SPPS) under standardized quality protocols in North America or relies on unverified, unrefined bulk imports.

Lot Traceability: Every vial must feature a clear batch number that links directly to verifiable raw analytical chromatograms stored in a public or client-accessible database.

Endotoxin Data: Essential vendors omit endotoxin testing entirely. High-tier suppliers provide quantitative LAL assay data for sensitive bioassays.

Shipping and Storage Speed: Lyophilized peptides degrade when exposed to prolonged thermal fluctuation. Reliable suppliers dispatch orders same-day in temperature-controlled packaging.

Technical Support: Access to technical specialists who understand peptide chemistry and can provide analytical clarification when needed.

Red flags when buying CJC-1295 (No DAC) online

To safeguard research integrity and budget resources, avoid vendors demonstrating any of the following commercial red flags:

Generic or Reused COAs: If the HPLC chromatogram lacks a unique lot number, date stamp, and integration table, or appears identical across multiple product listings, the analysis is likely fake or outdated.

Purity Stated Without Testing Method: Claims of '99% purity' without supporting RP-HPLC baseline integration curves and MS spectrum plots are unverified marketing assertions.

Absence of Mass Spectrometry Data: HPLC alone confirms that a compound is pure, but it cannot confirm that the compound is actually CJC-1295 (No DAC). Without mass spectrometry, you cannot rule out amino acid sequence scramble or incorrect chain lengths.

Medical or Dosing Advice: Vendors offering dosage calculators, human administration guidelines, or therapy protocols violate regulatory standards. Legitimate research vendors sell exclusively for in vitro and laboratory evaluation.

Unusually Low Mass Pricing: Uncharacteristically cheap reagents usually indicate low net peptide content, high TFA salt contamination, or heavy microbial endotoxins due to skipped purification steps.

Synergistic research protocols with GHRH analogs and GHRPs

In neuroendocrine and tissue regeneration studies, GHRH analogs like CJC-1295 (No DAC) are frequently investigated alongside Growth Hormone Releasing Peptides (GHRPs) or ghrelin receptor agonists.

While GHRH analogs bind to the GHRH receptor to stimulate adenylate cyclase and increase intracellular cyclic AMP (cAMP), GHRPs such as Ipamorelin or GHRP-2 operate through the Growth Hormone Secretagogue Receptor (GHS-R1a) to increase intracellular calcium ions. Preclinical literature demonstrates that co-administration of these two distinct receptor agonist classes produces a synergistic release of growth hormone in cellular models, exceeding the additive total of either compound evaluated in isolation.

Researchers evaluating secretagogue interactions can review protocol design literature across our published research peptide articles or explore comparative compounds such as Sermorelin for alternative GHRH sequence studies.

Ordering CJC-1295 (No DAC) from PX1 Research

When purchasing reagents for analytical or cell-based research, PX1 Research provides guaranteed sequence identity, high purity percentages, and full lot documentation.

What Ships: Each unit arrives as a vacuum-sealed, lyophilized cake containing 2 mg or 5 mg of active peptide mass, packaged in high-grade borosilicate glass vials with flip-off tamper-evident seals to protect against moisture intrusion and oxidation.

Fulfillment & Shipping Speed: Orders placed before 3:00 PM EST Monday through Friday dispatch same-day from our centralized fulfillment centers in California and Arizona. Fast, fully tracked domestic shipping ensures minimal transit stress on freeze-dried sequences.

Quality Access: Every order includes instant access to batch-specific COAs, featuring raw RP-HPLC chromatograms, ESI-MS spectra, and endotoxin assay results.

Support & Bulk Orders: Our technical team is available to assist with analytical interpretation or volume quotes. To secure reagents for your lab, buy CJC-1295 (No DAC) 5 mg vials directly from our online store or apply for a wholesale peptide account.

Frequently Asked Questions

What purity percentage is required for CJC-1295 (No DAC) in research?

For reliable in vitro and animal models, CJC-1295 (No DAC) should have a purity percentage of at least 98.0% as determined by RP-HPLC. Purity levels below 95.0% contain truncated sequences and synthesis artifacts that interfere with receptor binding assays.

What is the difference between CJC-1295 (No DAC) and CJC-1295 with DAC?

CJC-1295 (No DAC) lacks the Drug Affinity Complex (DAC) maleimidopropionic acid linker. Consequently, it has a shorter physiological half-life and a exact molecular weight of 3288.70 Da, whereas CJC-1295 with DAC binds covalently to serum albumin.

Do you provide a COA for my specific lot of CJC-1295 (No DAC)?

Yes, PX1 Research provides lot-specific Certificates of Analysis for every batch. Each COA includes complete RP-HPLC purity chromatograms, mass spectrometry identity confirmation, net peptide content analysis, and endotoxin test results.

How is CJC-1295 (No DAC) purity tested?

Purity is evaluated using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) at 214/220 nm to measure peak area percentage. Molecular identity is independently verified using Electrospray Ionization Mass Spectrometry (ESI-MS).

What is net peptide content versus total vial mass?

Total vial mass includes the target peptide plus residual counterions (such as TFA) and bound moisture. Net peptide content (typically 75-88%) represents the exact percentage of dry weight that is pure active peptide protein.

How fast does PX1 Research ship CJC-1295 (No DAC)?

Orders placed before 3:00 PM EST, Monday through Friday, ship the same day from our logistics hubs in California and Arizona via tracked domestic carriers.

What endotoxin limit is acceptable for CJC-1295 (No DAC)?

High-purity research peptides should contain endotoxin levels below 0.5 EU/mg. For sensitive cell line assays, levels below 0.1 EU/mg are recommended to prevent false inflammatory responses.

Is CJC-1295 (No DAC) legal to buy in the US?

Yes, CJC-1295 (No DAC) is legal to purchase in the United States by qualified institutions and researchers for laboratory, in vitro, and preclinical research purposes. It is not approved for human or veterinary use.

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.